TW306919B - - Google Patents

Download PDF

Info

Publication number
TW306919B
TW306919B TW083111363A TW83111363A TW306919B TW 306919 B TW306919 B TW 306919B TW 083111363 A TW083111363 A TW 083111363A TW 83111363 A TW83111363 A TW 83111363A TW 306919 B TW306919 B TW 306919B
Authority
TW
Taiwan
Prior art keywords
group
gas
compound
alkyl
hydroxy
Prior art date
Application number
TW083111363A
Other languages
English (en)
Chinese (zh)
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Application granted granted Critical
Publication of TW306919B publication Critical patent/TW306919B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/16—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6536—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
    • C07F9/6544—Six-membered rings
    • C07F9/6547—Six-membered rings condensed with carbocyclic rings or carbocyclic ring systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
TW083111363A 1993-12-09 1994-12-07 TW306919B (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP30913193 1993-12-09

Publications (1)

Publication Number Publication Date
TW306919B true TW306919B (enExample) 1997-06-01

Family

ID=17989274

Family Applications (1)

Application Number Title Priority Date Filing Date
TW083111363A TW306919B (enExample) 1993-12-09 1994-12-07

Country Status (10)

Country Link
US (1) US5547952A (enExample)
EP (1) EP0657444B1 (enExample)
KR (1) KR950017982A (enExample)
CN (1) CN1109882A (enExample)
AT (1) ATE178323T1 (enExample)
CA (1) CA2137626A1 (enExample)
DE (1) DE69417523T2 (enExample)
FI (1) FI945762A7 (enExample)
NO (1) NO944762L (enExample)
TW (1) TW306919B (enExample)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3923709A (en) * 1974-08-30 1975-12-02 Monsanto Co 3,4-Dihydro-3-oxo-2H-1,4-benzothiazines and benzoxazines
US4078062A (en) * 1976-10-28 1978-03-07 E. R. Squibb & Sons, Inc. Substituted 2H-1,4-benzothiazin-3(4H)-ones
US4584300A (en) * 1983-02-07 1986-04-22 Santen Pharmaceutical Co., Ltd. Platelet anti-aggregative- and calcium antagonistic -1,4-benzothiazin-3-one derivatives, compositions, and methods of use therefor
GB8413915D0 (en) * 1984-05-31 1984-07-04 Wellcome Found Phenothiazine compounds
JPH0730058B2 (ja) * 1988-05-14 1995-04-05 参天製薬株式会社 ３−オキソ−１，４−ベンゾチアジン誘導体
WO1994005647A1 (fr) * 1992-08-31 1994-03-17 Santen Pharmaceutical Co., Ltd. Derive de 3-oxo-1,4-benzothiazine

Also Published As

Publication number Publication date
CN1109882A (zh) 1995-10-11
CA2137626A1 (en) 1995-06-10
FI945762A0 (fi) 1994-12-08
NO944762L (no) 1995-06-12
FI945762L (fi) 1995-06-10
US5547952A (en) 1996-08-20
ATE178323T1 (de) 1999-04-15
EP0657444B1 (en) 1999-03-31
FI945762A7 (fi) 1995-06-10
KR950017982A (ko) 1995-07-22
NO944762D0 (no) 1994-12-08
EP0657444A1 (en) 1995-06-14
DE69417523T2 (de) 1999-09-16
DE69417523D1 (de) 1999-05-06

Similar Documents

Publication Publication Date Title
CN114195799B (zh) 吡嗪类衍生物及其在抑制shp2中的应用
TW202444B (enExample)
JPH07501330A (ja) 新規な置換されたサリチル酸
SU1554763A3 (ru) Способ получени производных тиазола или их солей с щелочными металлами
JP5878484B2 (ja) 新規のｓ−ニトロソグルタチオンレダクターゼ阻害剤
JPS58146583A (ja) ピラゾロオキサジン類、ピラゾロチアジン類及びピラゾロキノリン類
TW397831B (en) The anti-platelet-agglutination hexahydrogenated pyridine and its derivatives
JPS6388182A (ja) イミダゾピリジン誘導体及び医薬組成物
JPS61263969A (ja) アスコルビン酸誘導体含有製剤
TW539676B (en) Substituted pyrroles
JPH04330088A (ja) グリチルレチン酸誘導体
TW460465B (en) 1,2,3,4-tetrahydroquinoline derivatives, preparation process thereof, and pharmaceutical compositions containing the same
TW438746B (en) New phenylamidine derivatives, processes for preparing them and their use as pharmaceutical compositions
WO2020107500A1 (zh) 2-(1-酰氧正戊基)苯甲酸与碱性氨基酸或氨基胍形成的盐、其制备方法及用途
CN102724975A (zh) IRE-1α抑制剂
US4258047A (en) Pyrazole derivatives, pharmaceutical formulations thereof
CN112174945B (zh) 具有抗癌作用的吲唑类化合物及其制备方法和用途
JP3083842B2 (ja) 新規かつ強力な最終分化誘発剤及びその使用方法
TW306919B (enExample)
US5719180A (en) Chroman derivatives having vitamin E-like activities
TW416957B (en) Novel purine derivatives and pharmaceutically acceptable salt thereof
WO1982003393A1 (fr) Derives de l'acide ascorbique
BR112017019824B1 (pt) Composto e composição farmacêutica
CN101516823A (zh) 用于治疗认知性、神经变性或神经元性疾病或病症的苯基-异戊二烯基-醚衍生物
CN102212058B (zh) “单一的复合药”：手性含氮杂环酯、合成法及其在制备低毒性cb1受体抑制剂中的应用